HQ
  • About A*STAR
    • Corporate Profile
      • A*STAR Board Members
      • Senior Management
      • Organisation Structure
      • Corporate Social Responsibility
      • Diversity at A*STAR
      • A*STAR Sustainability
    • Annual Report
    • A*STAR Global Network
  • Research
    • About A*STAR Research
    • Funding Opportunities
    • S-SEAF
    • Research Ethics
    • Biomedical Research Council
    • Science and Engineering Research Council
    • Our People
      • Highly Cited Researchers
      • Honours and Accolades
  • Innovation & Enterprise
    • About I&E
    • Innovation Offerings
  • Scholarships
  • News
    • A*STAR News
      • Publicity Highlights
      • Press Releases
      • Features
      • Committee Of Supply (COS) Debate
    • Case Studies
    • Faces of A*STAR
    • National Survey of RIE
    • Connect with Us
  • Career
  • Home
  • News
  • A*STAR News
  • Visits
  • A*STAR News
    • Publicity Highlights
    • Press Releases
    • Features
    • Committee Of Supply (COS) Debate
  • Case Studies
  • Faces of A*STAR
  • National Survey of RIE
  • Connect with Us
Agency for Science, Technology and Research (A*STAR)
PartnershipsCareersSuppliersContact UsWhistleblowing
  • Report Vulnerability
  • Privacy Statement
  • Terms & Conditions
  • Visits

    Deputy Prime Minister Teo Chee Hean's visit to ETC

    13 Feb 2017
    • Whatsapp
    • Telegram
    • Facebook
    • Twitter
    • Email
    • Linked In

    Deputy Prime Minister Teo Chee Hean's visit to ETC on 13 Feb 2017

    Deputy Prime Minister Teo Chee Hean visited A*STAR on Monday- 13 February 2017- to learn more about Singapore’s drug discovery and development landscape. He toured the Singapore Screening Centre which is critical to A*STAR’s drug discovery efforts. The Singapore Screening Centre is a drug screening platform within A*STAR’s Experimental Therapeutics Centre (ETC) that provides a full spectrum of state-of-the-art automation technologies to biomedical researchers- enabling highly efficient drug screening in one location. The Singapore Screening Centre conducts high-throughput screening to identify potential drug candidates against disease- using a library of over 500-000 chemical compounds.